All Stories

  1. Breath biopsy biomarkers: cell-free nucleic acids in exhaled breath condensate
  2. Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing
  3. Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application
  4. New Possible Ways to Use Exosomes in Diagnostics and Therapy via JAK/STAT Pathways
  5. Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase
  6. Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer
  7. Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells
  8. Suppressing the PI3K/AKT Pathway by miR-30d-5p Mimic Sensitizes Ovarian Cancer Cells to Cell Death Induced by High-Dose Estrogen
  9. Extracellular Nucleic Acids in the Diagnosis and Progression of Colorectal Cancer
  10. Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome
  11. The Role of Exosomes in Cancer Progression
  12. DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects
  13. Structure of the dihydrolipoamide succinyltransferase (E2) component of the human alpha-ketoglutarate dehydrogenase complex (hKGDHc) revealed by cryo-EM and cross-linking mass spectrometry: Implications for the overall hKGDHc structure
  14. Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients
  15. Comparative Analysis of Cell-Free miR-205-5p, let-7f-5p, and miR-483-5p Expression in Ovarian Cell Cultures and Plasma Samples of Patients with Ovarian Cancer
  16. Copy Number Variation: Methods and Clinical Applications
  17. The Cell-Free Expression of MiR200 Family Members Correlates with Estrogen Sensitivity in Human Epithelial Ovarian Cells
  18. Novel Molecular Markers in Glioblastoma—Benefits of Liquid Biopsy
  19. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application
  20. Quantification of mtDNA in extracellular vesicles
  21. Cell-Free Nucleic Acids
  22. EP908 Expression of CD24 in ovarian cancer
  23. Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients
  24. Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples
  25. Copy number variants detection by microarray and multiplex ligation-dependent probe amplification in congenital heart diseases
  26. Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer
  27. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients
  28. PITX2 and NEURL1 SNP polymorphisms in Hungarian atrial fibrillation patients determined by quantitative real-time PCR and melting curve analysis
  29. Quantification of peripheral whole blood, cell-free plasma and exosome encapsulated mitochondrial DNA copy numbers in patients with atrial fibrillation
  30. Quantitative RT-PCR-based miRNA profiling of blastemal Wilms’ tumors from formalin-fixed paraffin-embedded samples
  31. Significance of liquid biopsy in glioblastoma – A review
  32. Uncertainty of fetal fraction determination in Non-Invasive Prenatal Screening by highly polymorphic SNPs
  33. Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer
  34. Identification of miR-146a and miR-196a-2 single nucleotide polymorphisms at patients with high-grade serous ovarian cancer
  35. Noninvasive prenatal testing for congenital heart disease – cell-free nucleic acid and protein biomarkers in maternal blood
  36. cell-free nucleic acids, cardiovascular diseases, diagnosis
  37. application of cell-free nucleic acids in diagnosis of different diseases
  38. Various levels of circulating exosomal total-miRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension
  39. Identifying miRNA regulatory mechanisms in preeclampsia by systems biology approaches
  40. A „szabad” nukleinsavak jelentősége a noninvazív diagnosztikában
  41. Rare novel variants in the ZIC3 gene cause X-linked heterotaxy
  42. Genetic predisposition in patients with hypertension and normal ejection fraction to oxidative stress
  43. Utilization of Benchtop Next Generation Sequencing Platforms Ion Torrent PGM and MiSeq in Noninvasive Prenatal Testing for Chromosome 21 Trisomy and Testing of Impact of In Silico and Physical Size Selection on Its Analytical Performance
  44. Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study
  45. Elevated hsa-miR-99a levels in maternal plasma may indicate congenital heart defects
  46. Application of real-time polymerase chain reaction in the clinical genetic practice
  47. sex chromosomal aneuploidies in Hungary
  48. Trends in maternal mortality in Hungary between 1978 and 2010
  49. Association of specific diplotypes defined by common rs1800682 and rare rs34995925 single nucleotide polymorphisms within the STAT1 transcription binding site of the FAS gene promoter with preeclampsia
  50. Genetic Aspects of Preeclampsia and the HELLP Syndrome
  51. Increased B-type natriuretic peptide levels in early-onset versus late-onset preeclampsia
  52. Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational study
  53. Lower risk for Down syndrome associated with longer oral contraceptive use: a case–control study of women of advanced maternal age presenting for prenatal diagnosis
  54. Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy
  55. Effects of curcumin on global gene expression profiles in the highly invasive human breast carcinoma cell line MDA‑MB 231: A gene network-based microarray analysis
  56. cell-free nucleic acids for fetal aneuploidies
  57. Role of hsa-miR-325 in the etiopathology of preeclampsia
  58. Letter to the Editor
  59. Natriuretic peptide precursor B gene (TTTC)n microsatellite polymorphism in pre-eclampsia
  60. Microarray Profiling Reveals That Placental Transcriptomes of Early-onset HELLP Syndrome and Preeclampsia Are Similar
  61. Outcome of patients with mantle cell lymphoma is not influenced by vascular endothelial growth factor polymorphisms
  62. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia
  63. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders
  64. Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis
  65. miRNA-325 in preeclampsia
  66. Vascular Endothelial Growth Factor Polymorphisms in Mantle Cell Lymphoma
  67. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia
  68. Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia
  69. dorsolumbosacral agenesis
  70. Overrepresentation of BclI polymorphism of the glucocorticoid receptor gene in pregnant women with HELLP syndrome
  71. Association of extracellular superoxide dismutase (SOD3) Ala40Thr gene polymorphism with pre-eclampsia complicated by severe fetal growth restriction
  72. Dystrophin gene analysis in Hungarian Duchenne/Becker muscular dystrophy families – Detection of carrier status in symptomatic and asymptomatic female relatives
  73. Leptin gene (TTTC)n microsatellite polymorphism in pre-eclampsia and HELLP syndrome
  74. Muscular dystrophies: diagnostic approaches in Hungary
  75. G.P.7.06 Dystrophin gene analysis in Hungarian Duchenne/Becker muscular dystrophy families-detection of carrier status in symptomatic and asymptomatic female relatives
  76. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome
  77. Overexpression of CD24, c-myc and Phospholipase 2A in Prostate Cancer Tissue Samples Obtained by Needle Biopsy
  78. Elevated serum 70 kDa heat shock protein level reflects tissue damage and disease severity in the syndrome of hemolysis, elevated liver enzymes, and low platelet count
  79. Association between tumor necrosis factor (TNF)-α G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction
  80. ERBB receptors in developing, dysplastic and malignant oral epithelia
  81. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses
  82. Gene network and canonical pathway analysis in prostate cancer: a microarray study
  83. The risk of shoulder dystocia related permanent fetal injury in relation to birth weight
  84. Under-Expression of <i>CD24</i> in Pre-Eclamptic Placental Tissues Determined by Quantitative Real-Time RT-PCR
  85. RAF-1 over-expression does condition survival of patients affected by aggressive mantle cell lymphoma
  86. Shoulder dystocia related fetal neurological injuries: the predisposing roles of forceps and ventouse extractions
  87. P150 Expression of ZAP-70, RAF-1 and C-MYC in B-cell lymphomas and chronic leukaemia. Overexpression of ZAP70 predicts poor survival in mantle cell lymphoma
  88. O09 Study of the most common inherited thrombophilias in HELLP syndrome patients
  89. Chlamydia trachomatis infection, Fallopian tube damage and a mannose-binding lectin codon 54 gene polymorphism
  90. Genetic Changes in Sporadic Keratocystic Odontogenic Tumors (Odontogenic Keratocysts)
  91. Serum heat shock protein 70 levels are decreased in normal human pregnancy
  92. prenatal detection of Toxoplasma gondii
  93. Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor α (ESR1) PvuII and XbaI gene polymorphisms
  94. Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum α 2 -HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count
  95. Mannose-binding lectin (MBL) codon 54 gene polymorphism protects against development of pre-eclampsia, HELLP syndrome and pre-eclampsia-associated intrauterine growth restriction
  96. Factor V Leiden and apolipoprotein E genotypes in severe femoropopliteal atherosclerosis with restenosis
  97. Novel mutation in OTC gene causes neonatal death in twin brothers
  98. Characteristic Laboratory Changes in Pregnancies Complicated by HELLP Syndrome
  99. Evaluation of theMDR1,ABCG2,Topoisomerases IIαandGSTπgene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen
  100. High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR
  101. Reliable detection of Trisomy 21 using MALDI-TOF mass spectrometry
  102. Use of Routinely Collected Amniotic Fluid for Whole-Genome Expression Analysis of Polygenic Disorders
  103. Detection of Δ<i>F508del</i> Using Quantitative Real-Time PCR, Comparison of the Results Obtained by Fluorescent PCR
  104. Presence of Cell-Free Fetal DNA in Plasma of Women with Ectopic Pregnancies,
  105. Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case–control study
  106. DNA copy number amplification profiling of human neoplasms
  107. Detection of Toxoplasma gondii from amniotic fluid, a comparison of four different molecular biological methods
  108. Detection of maternal deoxyribonucleic acid in peripheral blood of premature and mature newborn infants
  109. Glycodelin reduces carcinoma-associated gene expression in endometrial adenocarcinoma cells
  110. The DNA isolation method has effect on allele drop-out and on the results of fluorescent PCR and DNA fragment analysis
  111. Rapid determination of trisomy 21 from amniotic fluid cells using single-nucleotide polymorphic loci
  112. Myllykangas et al. Helicobacter pylori Infection Activates FOS and Stress‐Response Genes and Alters Expression of Genes in Gastric Cancer–Specific Loci. Genes Chromosomes Cancer 2004; 40:334–341
  113. Chlamydia pneumoniae in coronary bypass grafts of redo patients. The concept of the ‘adventitial baseline infection’
  114. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia
  115. L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray
  116. Molecular mechanisms of CD99-induced caspase-independent cell death and cell–cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators
  117. Real-Time PCR analysis of af4 and dek genes expression in acute promyelocytic leukemia t (15;17)patients
  118. Helicobacter pyloriinfection activatesFOSand stress‐response genes and alters expression of genes in gastric cancer–specific loci
  119. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays
  120. Coamplified and overexpressed genes at ERBB2 locus in gastric cancer
  121. Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene
  122. Real-time PCR analysis of the apoptosis related genes in ATRA treated APL t(15;17) patients
  123. Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma
  124. Aberrant Expression ofHOXA9,DEK,CBLandCSF1Rin Acute Myeloid Leukemia
  125. Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma
  126. Expression of myeloid-specific genes in childhood acute lymphoblastic leukemia – a cDNA array study
  127. Rapid diagnosis of triploidy of maternal origin using fluorescent PCR and DNA fragment analysis in the third trimester of pregnancy
  128. Gene expression analysis of 1,25(OH)2D3‐dependent differentiation of HL‐60 cells: a cDNA array study
  129. Factor V Leiden mutation and preeclampsia
  130. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion
  131. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 −2518 G/G genotype in CAD patients
  132. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA) polymorphism with coronary heart disease
  133. Apolipoprotein E Allele Distribution in Trisomy 13, 18, and 21 Conceptuses in a Hungarian Population
  134. MATERNAL AND NEONATAL OUTCOME OF PREECLAMPTIC PREGNANCIES: THE POTENTIAL ROLES OF FACTOR V LEIDEN MUTATION AND 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE
  135. Unusual cases of severe thrombotic episodes during the peripartum period
  136. P-004. Comparison of molecular biological and conventional methods for the detection of Chlamydia trachomatis in the semen
  137. Apolipoprotein E gene polymorphism frequencies in a sample of healthy Hungarians
  138. Mutation in the factor V gene associated with inferior vena cava thrombosis in newborns
  139. Prenatal detection of trisomy 13 from amniotic fluid by quantitative fluorescent polymerase chain reaction
  140. Apolipoprotein E alleles in women with severe pre-eclampsia.
  141. Prenatal detection of trisomy 21 and 18 from amniotic fluid by quantitative fluorescent polymerase chain reaction.
  142. Downward Blotting of Proteins in a Model Based on Apolipoprotein(a) Phenotyping
  143. Enzyme-Linked Immunosorbent Assay for Detection of Serum Antibody to Blastocystis hominis in Symptomatic Infections
  144. Pulsed‐field gel electrophoresis for the separation of large protein molecules exemplified by the isoforms of apolipoprotein (a)
  145. Antibody Response to Blastocystis hominis Infections
  146. The occurrence of Chlamydia trachomatis in the semen of men participating in an IVF programme